{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/16/3312463/0/en/Clearmind-Medicine-Completes-Dosing-for-Part-A-of-its-of-FDA-Regulated-Phase-I-II-Clinical-Trial.html", "message": "News view counter 801589 successfully enlarged"}